深圳法院判決慶鈴汽車(01122.HK)及其他相關擔保人需劃撥合共1.38億人幣財產 公司正申請再審
慶鈴汽車(01122.HK)公布,於12月12日收到深圳法院日期11月4日之執行裁定書,具體判決情況為:查封、凍結或劃撥該客戶、相關擔保人,及公司約1.38億元人民幣之財產,其中公司承擔補充清償責任。
基於該執行裁定書的裁定,公司自2015年8月16日起被凍結的銀行結餘由7,999.9萬元增至約1.38億元人民幣。就以上增加的凍結金額,公司正與核數師商討會否需要作出進一步撥備。當落實後,公司將會在需要的情況下作出公告。
公司已向最高人民法院申請再審,並有待該法院決定是否受理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.